Briefing
Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy.
Positive in 83% of those who developed BC; combined with cytology, 95%.
- n: 570 at risk for BC; 56 UTUC; surveillance subset
- Assay: UroSEEK: 11 genes plus copy-number changes on 39 chromosome arms